Last mentioned: Mar 12, 2026
Lead Counsel Appointment
Expected timeframe for the court to designate the lead plaintiff and legal representation.
Lead Plaintiff Deadline
Final day for affected investors to petition the court to lead the class action.
Lead Plaintiff Deadline
The final date for investors to petition the court to lead the class action lawsuit.
Lawsuit Announcements
Schall Law Firm files class action notices for Soleno Therapeutics and Ultragenyx Pharmaceutical.
Legal Counsel Announcement
Rosen Law Firm publicly encourages investors to secure counsel before the upcoming deadline.
Class Period Ends
The final date of the period covered by the lawsuit, often following a corrective disclosure.
Class Period Begins
The start date for alleged misleading statements or omissions by Enphase Energy.
The Schall Law Firm has initiated securities fraud class actions against Soleno Therapeutics and Ultragenyx Pharmaceutical, alleging violations of federal securities laws. The firm is currently seeking lead plaintiffs to represent the class in these high-stakes biotech litigations following potential misrepresentations to the market.
Enphase Energy, Inc. is facing a significant securities class action lawsuit alleging that the company issued materially false or misleading statements during a critical growth period in 2025. The Rosen Law Firm has set an April 20, 2026, deadline for investors who suffered losses between April and October 2025 to seek lead plaintiff status.
Renewed trade tensions are disrupting global supply chains and forcing a re-evaluation of multinational corporate valuations. Investors must pivot toward domestic-centric sectors and resilient supply chain leaders to mitigate the risks of escalating tariff regimes.
Renewed trade hostilities and tariff escalations are forcing a radical restructuring of global supply chains. Logistics providers and manufacturers are pivoting toward regionalization as 'just-in-case' inventory strategies replace the traditional 'just-in-time' model.